Decreased osteocalcin serum levels (a marker of bone formation) and increased levels of CTX in untreated premenopausal SLE patients have been observed, with a correlation between osteocalcin and disease activity (119). The gene discussed is BGLAP; the disease is systemic lupus erythematosus.